JPH0684331B2 - Process for producing aromatic substituted alkylcarboxylic acid compound - Google Patents
Process for producing aromatic substituted alkylcarboxylic acid compoundInfo
- Publication number
- JPH0684331B2 JPH0684331B2 JP60159317A JP15931785A JPH0684331B2 JP H0684331 B2 JPH0684331 B2 JP H0684331B2 JP 60159317 A JP60159317 A JP 60159317A JP 15931785 A JP15931785 A JP 15931785A JP H0684331 B2 JPH0684331 B2 JP H0684331B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- substituted
- aromatic
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002253 acid Substances 0.000 title claims description 16
- 150000001875 compounds Chemical class 0.000 title claims description 16
- 125000003118 aryl group Chemical group 0.000 title claims description 10
- 238000000034 method Methods 0.000 title description 22
- -1 aromatic halide Chemical class 0.000 claims description 39
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 35
- 239000003054 catalyst Substances 0.000 claims description 14
- 238000006114 decarboxylation reaction Methods 0.000 claims description 13
- 230000007062 hydrolysis Effects 0.000 claims description 13
- 238000006460 hydrolysis reaction Methods 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 150000002825 nitriles Chemical group 0.000 claims description 8
- MLIREBYILWEBDM-UHFFFAOYSA-N anhydrous cyanoacetic acid Natural products OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 239000003446 ligand Substances 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 5
- 150000002941 palladium compounds Chemical class 0.000 claims description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- LLVWLCAZSOLOTF-UHFFFAOYSA-N 1-methyl-4-[1,4,4-tris(4-methylphenyl)buta-1,3-dienyl]benzene Chemical compound C1=CC(C)=CC=C1C(C=1C=CC(C)=CC=1)=CC=C(C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 LLVWLCAZSOLOTF-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- WMVSVUVZSYRWIY-UHFFFAOYSA-N [(4-benzoyloxyiminocyclohexa-2,5-dien-1-ylidene)amino] benzoate Chemical compound C=1C=CC=CC=1C(=O)ON=C(C=C1)C=CC1=NOC(=O)C1=CC=CC=C1 WMVSVUVZSYRWIY-UHFFFAOYSA-N 0.000 claims description 3
- 150000001336 alkenes Chemical class 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 150000002527 isonitriles Chemical group 0.000 claims description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 3
- 125000003107 substituted aryl group Chemical group 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000001033 ether group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- 230000011987 methylation Effects 0.000 description 6
- 238000007069 methylation reaction Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical compound C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229960002390 flurbiprofen Drugs 0.000 description 3
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 229960000991 ketoprofen Drugs 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- PPLJMXYTVISZLI-UHFFFAOYSA-N 2-fluoro-4-iodo-1-phenylbenzene Chemical group FC1=CC(I)=CC=C1C1=CC=CC=C1 PPLJMXYTVISZLI-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- ARHWPKZXBHOEEE-UHFFFAOYSA-N alclofenac Chemical compound OC(=O)CC1=CC=C(OCC=C)C(Cl)=C1 ARHWPKZXBHOEEE-UHFFFAOYSA-N 0.000 description 2
- 229960005142 alclofenac Drugs 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003907 antipyretic analgesic agent Substances 0.000 description 2
- 150000001502 aryl halides Chemical class 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000004437 phosphorous atom Chemical group 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- QVGRURMQPVFYBL-UHFFFAOYSA-N (2,3,4-triphenylcyclobuta-1,3-dien-1-yl)benzene Chemical compound C1=CC=CC=C1C1=C(C=2C=CC=CC=2)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 QVGRURMQPVFYBL-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- WFPMUFXQDKMVCO-UHFFFAOYSA-N 2-(3-chlorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Cl)=C1 WFPMUFXQDKMVCO-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- LXUTYOVUICAOGH-UHFFFAOYSA-N 2-methylpropanedinitrile Chemical compound N#CC(C)C#N LXUTYOVUICAOGH-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical group C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- SHCKUIVCYUETGT-UHFFFAOYSA-N COCCO[Na].[Na] Chemical compound COCCO[Na].[Na] SHCKUIVCYUETGT-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 206010049590 Upper respiratory tract inflammation Diseases 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 125000005595 acetylacetonate group Chemical group 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- RCUIWQWWDLZNMS-UHFFFAOYSA-N benzyl 2-cyanoacetate Chemical compound N#CCC(=O)OCC1=CC=CC=C1 RCUIWQWWDLZNMS-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- DJACTCNGCHPGOI-UHFFFAOYSA-N butyl 2-cyanoacetate Chemical compound CCCCOC(=O)CC#N DJACTCNGCHPGOI-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical group C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical class [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- SEHASSDIPXUUSI-UHFFFAOYSA-N phenyl 2-cyanoacetate Chemical compound N#CCC(=O)OC1=CC=CC=C1 SEHASSDIPXUUSI-UHFFFAOYSA-N 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- FEMRXDWBWXQOGV-UHFFFAOYSA-N potassium amide Chemical class [NH2-].[K+] FEMRXDWBWXQOGV-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-OUBTZVSYSA-N potassium-40 Chemical compound [40K] ZLMJMSJWJFRBEC-OUBTZVSYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- NLFIMXLLXGTDME-UHFFFAOYSA-N propyl 2-cyanoacetate Chemical compound CCCOC(=O)CC#N NLFIMXLLXGTDME-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical class [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- CGRKYEALWSRNJS-UHFFFAOYSA-N sodium;2-methylbutan-2-olate Chemical compound [Na+].CCC(C)(C)[O-] CGRKYEALWSRNJS-UHFFFAOYSA-N 0.000 description 1
- UJTRRNALUYKHQE-UHFFFAOYSA-N sodium;diphenylmethylbenzene Chemical compound [Na+].C1=CC=CC=C1[C-](C=1C=CC=CC=1)C1=CC=CC=C1 UJTRRNALUYKHQE-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は芳香族置換アルキルカルボン酸化合物の製造法
に関する。TECHNICAL FIELD The present invention relates to a method for producing an aromatic-substituted alkylcarboxylic acid compound.
詳しくは慣用名例えば,アルクロフェナック,イブプロ
フェン,ナプロキセン,フルルビプロフェン,ケトプロ
フェン等解熱鎮痛消炎剤として利用される芳香族置換ア
ルキルカルボン酸化合物の製造法である。More specifically, it is a method for producing an aromatic substituted alkylcarboxylic acid compound used as an antipyretic analgesic and anti-inflammatory agent such as common names such as alclofenac, ibuprofen, naproxen, flurbiprofen and ketoprofen.
従来,芳香族置換アルキルカルボン酸の代表的製法とし
て次の方法(特公昭43-22297号)が知られている。Conventionally, the following method (Japanese Patent Publication No. Sho 43-22297) is known as a typical method for producing an aromatic-substituted alkylcarboxylic acid.
また特開昭60-11439号には,溶媒にヘキサメチル燐酸ト
リアミド又はN−メチルピロリドンを,触媒にヨウ化銅
をそれぞれ用いて,アリールハライドにシアノ酢酸エス
テルを作用させ,生成物を単離した後に,2−アリールア
ルキルカルボン酸に誘導する方法が記載されている。 Further, in JP-A-60-11439, hexamethylphosphoric triamide or N-methylpyrrolidone is used as a solvent, and copper iodide is used as a catalyst, and a cyanoacetic acid ester is allowed to act on an aryl halide to isolate a product. Methods for deriving 1,2-arylalkylcarboxylic acids are described.
しかし,前者の代表的製法は工程が非常に長く,当然に
収率が低くなり,工業的に有利ではない。また後者の方
法は特殊な溶媒の使用のほか,触媒の添加量が極めて多
く(例えばアリールハライド1モルに対し2モル添
加),事実上触媒反応とはいえない。However, the former typical production method has a very long process, and the yield is naturally low, which is not industrially advantageous. In the latter method, in addition to the use of a special solvent, the addition amount of the catalyst is extremely large (for example, 2 mol is added to 1 mol of the aryl halide), and it cannot be said that it is a catalytic reaction in fact.
本発明者等は種々研究の結果,特定のパラジウム−リン
触媒を極めて少量用いて行なえば,中間体を単離するこ
となく,少ない工程かつ高収率で,芳香族置換アルキル
カルボン酸が得られることを見出し,本発明に到った。As a result of various studies, the inventors of the present invention obtained an aromatic-substituted alkylcarboxylic acid in a small number of steps and in a high yield without isolation of an intermediate, when an extremely small amount of a specific palladium-phosphorus catalyst was used. The inventors have found out that, and have reached the present invention.
すなわち,本発明は,触媒,塩基性縮合剤及び溶媒の存
在下に, 一般式〔I〕 Ar-X 〔I〕 (式中Arは置換アリール基又は置換もしくは非置換複素
環式基を,Xは臭素原子又はヨウ素原子をそれぞれ示す)
で表わされる芳香族ハライドに 一般式〔II〕 〔式中Rは水素原子又はメチル基を,Yはシアン基又は基
−COOR1(R1はアルキル基,アラルキル基又はアリール
基)を示す〕で表わされるニトリル化合物を,触媒とし
て, 一般式〔IIIa〕〜〔IIIc〕 L2Pd(II)▲X* 2▼ 〔IIIa〕 L4Pd(O) 〔IIIb〕 QaPd(II)▲X* b▼+L 〔IIIc〕 〔式中Lは (R2,R3又はR4はアルキル基,アルケニル基,アラルキ
ル基,アリール基,シクロアルキル基,アルコキシ基又
はアリールオキシ基から独立して選ばれた基を示し,
R2,R3又はR4が他の分子のR2,R3又はR4と互に結合し,
少くとも1個のアルキレン基又はアルキレンエーテル基
を形成してL2を構成していてもよい)で表わされる配位
子を,Qはニトリル類,イソニトリル類,π−アリル,1,5
−ジエン類,1,3−ジエン類,ベンゾキノン又はオレフィ
ン類を示し,但しこれらの化合物はPd(II)錯体を形成
するものとしX*はハロゲン原子,基−OOCR5(R5は低級
アルキル基)又は を,a及びbは1又は2の整数をそれぞれ示す〕で表わさ
れる二価又はO価のパラジウム化合物から選ばれる少く
とも1種を用いて反応させ,相当する芳香族置換マロン
ニトリル又はシアン酢酸エステルとし,次いでこの化合
物を (a) 酸又はアルカリの存在下で加水分解し,加熱に
より脱炭酸を行なうか, (b) 塩基性縮合剤の存在下でメチルハライドにより
メチル化し,加水分解後加熱により脱炭酸を行なうこと
を特徴とする 一般式〔IV〕 (式中Ar及びRは前記と同じ意義を有する)で表わされ
る芳香族置換アルキルカルボン酸化合物の製造法であ
る。That is, in the present invention, in the presence of a catalyst, a basic condensing agent and a solvent, the general formula [I] Ar-X [I] (wherein Ar represents a substituted aryl group or a substituted or unsubstituted heterocyclic group, X Represents a bromine atom or an iodine atom respectively)
The aromatic halide represented by the general formula [II] [Wherein R represents a hydrogen atom or a methyl group, Y represents a cyan group or a group-COOR 1 (R 1 represents an alkyl group, an aralkyl group or an aryl group)], using a nitrile compound represented by the general formula [ IIIa] to [IIIc] L 2 Pd (II) ▲ X * 2 ▼ [IIIa] L 4 Pd (O) [IIIb] QaPd (II) ▲ X * b ▼ + L [IIIc] [where L is (R 2 , R 3 or R 4 represents a group independently selected from an alkyl group, an alkenyl group, an aralkyl group, an aryl group, a cycloalkyl group, an alkoxy group or an aryloxy group,
R 2, R 3 or R 4 is mutually bonded with R 2, R 3 or R 4 other molecules,
At least a ligand represented by the structure may be in) one of L 2 to form an alkylene group or an alkylene ether group, Q is a nitrile, isonitriles, .pi.-allyl, 1,5
-Diene, 1,3-diene, benzoquinone or olefin, provided that these compounds form a Pd (II) complex, X * is a halogen atom, and the group -OOCR 5 (R 5 is a lower alkyl group ) Or A and b each represent an integer of 1 or 2] and the reaction is carried out with at least one divalent or O-valent palladium compound, and the corresponding aromatic-substituted malonnitrile or cyanacetic acid ester is reacted. Then, this compound is (a) hydrolyzed in the presence of an acid or alkali and decarboxylated by heating, or (b) methylated with methyl halide in the presence of a basic condensing agent, and then heated after hydrolysis. General formula [IV] characterized by decarboxylation (Wherein Ar and R have the same meaning as described above), and a method for producing an aromatic-substituted alkylcarboxylic acid compound.
本発明方法において用いられる触媒は前記式L2Pd(II)
▲X* 2▼,L4Pd(O)又はQaPd(II)▲X* 2▼+Lで表
わされるパラジウム化合物である。Pd(II)は二価のパ
ラジウム,Pd(O)はO価のパラジウムを表わす。Lは
1分子中に1個のリン原子を有する配位子を意味し,1分
子中に2個のリン原子を有する配位子をL2として表わす
こともできる。さらに反応系中でL2Pd(II)▲X* 2▼が
わずかでも形成されれば,L2とPd(II)▲X* 2▼を別個
に添加でき,この場合の触媒系(L2+Pd(II)▲X
* 2▼)もL2Pd(II)▲X* 2▼と同等の意義を有する。The catalyst used in the method of the present invention has the formula L 2 Pd (II)
A palladium compound represented by ▲ X * 2 ▼, L 4 Pd (O) or QaPd (II) ▲ X * 2 ▼ + L. Pd (II) represents divalent palladium and Pd (O) represents O-valent palladium. L means a ligand having one phosphorus atom in one molecule, and a ligand having two phosphorus atoms in one molecule can also be represented as L 2 . Further, if even a small amount of L 2 Pd (II) ▲ X * 2 ▼ is formed in the reaction system, L 2 and Pd (II) ▲ X * 2 ▼ can be added separately, and in this case, the catalyst system (L 2 + Pd (II) ▲ X
* 2 ▼) also has the same meaning as L 2 Pd (II) ▲ X * 2 ▼.
一般式L2Pd(II)▲X* 2▼,L4Pd(O)又はQaPd(II)
▲X* 2▼+Lで表わされるパラジウム化合物において,L
又はL2の配位子としては,例えば(CH3)3P,(C2H5)3P,(CH
2=CHCH2)3P,(C3H7)3P,(C4H9)3P,(C5H11)3P,(C6H13)3P,
(C7H15)3P,(C8H17)3P,(C6H11)3P,(C6H5)3P,(CH3C6H4)
3P,(ClC6H4)3P,(CH3OC6H4)3P,(C6H5CH2)3P,(C4H9)2(C6H
5)P,(C4H9)(C6H5)2P,(CH3OC6H4)(C6H5)2P,(C6H5)2PCH2C
H2P(C6H5)2, (C6H5)2PCH2CH2OCH2CH2P(C6H5)2,(CH3O)3P,(C2H5O)3P,
(C3H7O)3P,(C4H9O)3P,(C5H11O)3P,(C8H17O)3P,(C6H5CH2
O)3P,(C6H5O)3P,(CH3C6H4O)3P,(ClC6H4O)3P,(CH3OC6H
4O)3P,(CH3O)(C6H5)2P,(C4H9O)2(C6H5)P,(CH3C6H4O)(C6
H5)2P,(C4H9O)(C6H5O)2Pなどのリン化合物が挙げられ
る。General formula L 2 Pd (II) ▲ X * 2 ▼, L 4 Pd (O) or QaPd (II)
In the palladium compound represented by ▲ X * 2 ▼ + L, L
Or, as the ligand of L 2 , for example, (CH 3 ) 3 P, (C 2 H 5 ) 3 P, (CH
2 = CHCH 2 ) 3 P, (C 3 H 7 ) 3 P, (C 4 H 9 ) 3 P, (C 5 H 11 ) 3 P, (C 6 H 13 ) 3 P,
(C 7 H 15 ) 3 P, (C 8 H 17 ) 3 P, (C 6 H 11 ) 3 P, (C 6 H 5 ) 3 P, (CH 3 C 6 H 4 )
3 P, (ClC 6 H 4 ) 3 P, (CH 3 OC 6 H 4 ) 3 P, (C 6 H 5 CH 2 ) 3 P, (C 4 H 9 ) 2 (C 6 H
5 ) P, (C 4 H 9 ) (C 6 H 5 ) 2 P, (CH 3 OC 6 H 4 ) (C 6 H 5 ) 2 P, (C 6 H 5 ) 2 PCH 2 C
H 2 P (C 6 H 5 ) 2, (C 6 H 5 ) 2 PCH 2 CH 2 OCH 2 CH 2 P (C 6 H 5 ) 2 , (CH 3 O) 3 P, (C 2 H 5 O) 3 P,
(C 3 H 7 O) 3 P, (C 4 H 9 O) 3 P, (C 5 H 11 O) 3 P, (C 8 H 17 O) 3 P, (C 6 H 5 CH 2
O) 3 P, (C 6 H 5 O) 3 P, (CH 3 C 6 H 4 O) 3 P, (ClC 6 H 4 O) 3 P, (CH 3 OC 6 H
4 O) 3 P, (CH 3 O) (C 6 H 5 ) 2 P, (C 4 H 9 O) 2 (C 6 H 5 ) P, (CH 3 C 6 H 4 O) (C 6
Examples thereof include phosphorus compounds such as H 5 ) 2 P and (C 4 H 9 O) (C 6 H 5 O) 2 P.
一般式QaPd(II)▲X* b▼で表わされるパラジウム錯体
において,Qとしては,例えばベンゾニトリル,ベンゾイ
ソニトリル,π−アリル,シクロヘキサジエン,シクロ
オクタジエン,ノルボルナジエン,ブタジエン,テトラ
フェニルシクロブタジエン,ベンゾキノン,スチレン,
π−シクロペンタジエニルなどが挙げられ,これらの化
合物はPd(II)化合物の存在によりそれぞれニトリルPd
(II)錯体,イソニトリルPd(II)錯体,π−アリルPd
(II)錯体,1,5−ジエンPd(II)錯体,1,3−ジエンPd
(II)錯体,ベンゾキノンPd(II)錯体,オレフィンPd
(II)錯体を形成する。一般式〔IIIc〕においては,こ
れらのPd(II)錯体に前記のリン化合物〔L〕を添加し
て用いることを意味する。In the palladium complex represented by the general formula QaPd (II) ▲ X * b ▼, Q is, for example, benzonitrile, benzoisonitrile, π-allyl, cyclohexadiene, cyclooctadiene, norbornadiene, butadiene, tetraphenylcyclobutadiene, benzoquinone. ,styrene,
π-Cyclopentadienyl, etc. are included, and these compounds have nitrile Pd due to the presence of Pd (II) compounds.
(II) complex, isonitrile Pd (II) complex, π-allyl Pd
(II) complex, 1,5-diene Pd (II) complex, 1,3-diene Pd
(II) complex, benzoquinone Pd (II) complex, olefin Pd
(II) forms a complex. In the general formula [IIIc], it means that the phosphorus compound [L] is added to the Pd (II) complex and used.
またX*としては,塩素原子,臭素原子,ヨウ素原子,基
−OOCCH3,基−OOCC2H5,基−OOCC3H7,基−OOCC4H9, などが挙げられる。Further, as X * , chlorine atom, bromine atom, iodine atom, group —OOCCH 3 , group —OOCC 2 H 5 , group —OOCC 3 H 7 , group —OOCC 4 H 9 , And so on.
本発明方法において,一般式〔II〕で表わされるニトリ
ル化合物と反応させる一般式〔I〕で表わされる芳香族
ハライドは置換アリールハライド及び複素環式ハライド
であり,例えば などが挙げられる。また前記例示のヨウ素化合物に対応
する臭素化合物も同様に本発明の製造法で用いることが
できる。前記例示の芳香族ハライドの分子中にカルボニ
ル基やアリルエーテル基が存在する場合には,予めケタ
ール基やベンジルエーテル基などに変換して保護してお
き,反応に用いることが好ましい。In the method of the present invention, the aromatic halide represented by the general formula [I], which is reacted with the nitrile compound represented by the general formula [II], is a substituted aryl halide or a heterocyclic halide. And so on. A bromine compound corresponding to the above-exemplified iodine compound can also be used in the production method of the present invention. When a carbonyl group or an allyl ether group is present in the molecule of the aromatic halide exemplified above, it is preferably converted into a ketal group, a benzyl ether group or the like in advance for protection and used for the reaction.
本発明方法において,芳香族ハライドと反応させるニト
リル化合物としては,例えばマロンニトリル,メチルマ
ロンニトリルなどのマロンニトリル,シアン酢酸メチ
ル,メチルシアン酢酸エチル,シアン酢酸エチル,シア
ン酢酸プロピル,シアン酢酸ブチル,シアン酢酸オクチ
ル,シアン酢酸ベンジル,シアン酢酸フェニルなどのシ
アン酢酸エステルが挙げられる。In the method of the present invention, examples of the nitrile compound to be reacted with the aromatic halide include malon nitrile such as malon nitrile and methyl malon nitrile, methyl cyanoacetate, ethyl methyl cyanoacetate, ethyl cyanoacetate, propyl cyanoacetate, butyl cyanoacetate and cyanide. Examples thereof include cyanoacetic acid esters such as octyl acetate, benzyl cyanoacetate and phenyl cyanoacetate.
芳香族ハライドとニトリル化合物を反応させる際に存在
させる塩基性縮合剤としては,例えばナトリウム,カリ
ウムなどのアルカリ金属,メトキシナトリウム,エトキ
シナトリウム,イリソプロポキシナトリウム,t−ブトシ
カリウム,t−アミロキシナトリウムなどのアルカリ金属
アルコラート,カリウムアミド,リチウムアミド,ナト
リウムアミドなどのアルカリアミド,水素化ナトリウ
ム,トリフェニルメチルナトリウムなどが挙げられる。Examples of the basic condensing agent that is present when the aromatic halide and the nitrile compound are reacted include alkali metals such as sodium and potassium, sodium methoxy, ethoxy sodium, irisopropoxy sodium, t-butoxy potassium, and t-amyloxy sodium. Examples thereof include alkali metal alcoholates, potassium amides, lithium amides, alkali amides such as sodium amides, sodium hydride, and triphenylmethyl sodium.
反応溶媒としては,例えばテトラヒドロフラン,エチレ
ングリコールジメチルエーテル,ジエチレングリコール
ジメチルエーテル,ジエチルエーテル,ジブチルエーテ
ル,ジオキサン,ヘキサメチルホスホルトリアミド,ジ
メチルホルムアミド及びこれらと炭化水素との混合溶媒
などが挙げられる。Examples of the reaction solvent include tetrahydrofuran, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethyl ether, dibutyl ether, dioxane, hexamethylphosphortriamide, dimethylformamide, and a mixed solvent thereof with a hydrocarbon.
反応温度は20〜150℃,好ましくは50〜80℃で行われ,
反応時間は温度によって変るが,例えば70℃で4時間以
上である。そして反応中は不活性ガス雰囲気下で行なう
ことが望ましい。The reaction temperature is 20 to 150 ° C, preferably 50 to 80 ° C,
The reaction time varies depending on the temperature, but is, for example, 70 ° C. for 4 hours or longer. It is desirable to carry out the reaction under an inert gas atmosphere.
芳香族ハライドとニトリル化合物を反応させるに当り,
パラジウム化合物触媒の添加量は両原料1モルに対して
1/10〜1/10000モル,好ましくは1/50〜1/500モルであ
る。また触媒に一般式QaPd(II)▲X* b▼+Lを用い
る場合,二価のパラジウム錯体と配位子化合物(L)と
の添加割合は,任意でよいが,好ましくは1:2(モル
比)である。When reacting an aromatic halide with a nitrile compound,
Addition amount of palladium compound catalyst to 1 mol of both raw materials
It is 1/10 to 1/10000 mol, preferably 1/50 to 1/500 mol. When the general formula QaPd (II) ▲ X * b ▼ + L is used for the catalyst, the addition ratio of the divalent palladium complex and the ligand compound (L) may be arbitrary, but preferably 1: 2 (mol Ratio).
このようにして得られた芳香族置換マロンニトリル又は
シアン酢酸エステルを(a)酸又はアルカリの存在下で
加水分解し,加熱により脱炭酸を行なうか,(b)塩基
性縮合剤の存在下でメチルハライドによりメチル化し,
加水分解後加熱により脱炭酸すれば一般式〔IV〕で表わ
される芳香族置換アルキルカルボン酸化合物を得ること
ができる。The aromatic-substituted malonnitrile or cyanoacetic acid ester thus obtained is hydrolyzed in the presence of (a) acid or alkali and decarboxylated by heating, or (b) in the presence of a basic condensing agent. Methylated with methyl halide,
After hydrolysis and decarboxylation by heating, an aromatic substituted alkylcarboxylic acid compound represented by the general formula [IV] can be obtained.
加水分解は通常,塩酸,硫酸等の酸を水で希釈した酸性
水溶液,水酸化ナトリウム,水酸化カリウム等のアルカ
リを水で希釈したアルカリ水溶液の存在下で行われる。
濃度はとくに限定されないが両水溶液とも5〜20規定で
ある。Hydrolysis is usually carried out in the presence of an acidic aqueous solution obtained by diluting an acid such as hydrochloric acid or sulfuric acid with water, or an alkaline aqueous solution obtained by diluting an alkali such as sodium hydroxide or potassium hydroxide with water.
The concentration is not particularly limited, but both aqueous solutions are 5 to 20 N.
脱炭酸反応は加水分解後,酸性又はアルカリ水溶液を加
熱すれば容易に行なわれる。加熱温度は80〜150℃,好
ましくは110〜130℃である。加熱時間は15時間以内で十
分である。The decarboxylation reaction is easily performed by heating an acidic or alkaline aqueous solution after hydrolysis. The heating temperature is 80 to 150 ° C, preferably 110 to 130 ° C. A heating time of 15 hours or less is sufficient.
芳香族置換マロンニトリル又はシアン酢酸エステルのメ
チル化は,塩基性縮合剤と溶媒の存在下でメチルハライ
ドを作用させることにより行われる。塩基性縮合剤とし
ては,芳香族ハライドとニトリル化合物の反応に用いた
前記と同じものが使用され,溶媒としては,同反応に用
いた前記と同じものと,ほかにメタノール,エタノー
ル,プロパノールなどのアルコールが使用される。メチ
ルハライドとしてはヨウ化メチル,臭化メチルが挙げら
れる。反応は20〜150℃,好ましくは50〜80℃で行なわ
れ,数時間で完了する。Methylation of aromatic substituted malon nitrile or cyanoacetic acid ester is performed by reacting methyl halide in the presence of a basic condensing agent and a solvent. As the basic condensing agent, the same ones as those used in the reaction of the aromatic halide and the nitrile compound are used, and as the solvent, the same ones as those used in the same reaction as well as methanol, ethanol, propanol and the like are used. Alcohol is used. Examples of methyl halides include methyl iodide and methyl bromide. The reaction is carried out at 20 to 150 ° C, preferably 50 to 80 ° C, and is completed in several hours.
こうして得られた芳香族置換アルキルカルボン酸化合物
は必要により再結晶,カラムクロマトグラフィーなどの
方法により精製される。If necessary, the aromatic-substituted alkylcarboxylic acid compound thus obtained is purified by a method such as recrystallization or column chromatography.
本発明方法によれば,芳香族ハライドとニトリル化合物
を極めて少量の触媒を使用して反応させることができ,
その上に高収率,高純度で芳香族置換マロンニトリル又
はシアン酢酸エステルとしうるので,単離精製すること
なく,次のメチル化,加水分解及び脱炭酸工程を行なう
ことができる。したがって従来の工程を大巾に簡略化で
き,工業的に極めて有利な方法である。According to the method of the present invention, an aromatic halide and a nitrile compound can be reacted using an extremely small amount of catalyst,
Furthermore, since aromatic substituted malon nitrile or cyanoacetic acid ester can be obtained in high yield and high purity, the subsequent methylation, hydrolysis and decarboxylation steps can be performed without isolation and purification. Therefore, the conventional process can be greatly simplified and is an industrially extremely advantageous method.
本発明で得られた芳香族置換アルキルカルボン酸化合物
は,そのままで,又はエステル化,ナトリウム塩,カル
シウム塩などとして,例えば慢性関節リウマチ,その他
の膠原痛に伴う関節炎,上気道炎,腰痛症などの消炎,
鎮痛,外傷,手術及び抜歯後の消炎,鎮痛に適用できる
解熱鎮痛消炎剤として利用される。The aromatic-substituted alkylcarboxylic acid compound obtained by the present invention is used as it is or as an esterification, sodium salt, calcium salt, etc., for example, rheumatoid arthritis, other arthritis associated with collagen pain, upper respiratory tract inflammation, low back pain, etc. Extinction,
It is used as an antipyretic analgesic and anti-inflammatory agent applicable to analgesia, trauma, anti-inflammatory after surgery and tooth extraction, and analgesia.
次に実施例を挙げて本発明を説明する。Next, the present invention will be described with reference to examples.
実施例1 イブプロフェンの合成(A法) 還流冷却器,攪拌機,滴下漏斗及び温度計を備えた三ツ
口フラスコに,窒素気流中,t−ブトキシカリウム2469mg
(22mmol),トリフェニルホスフィン105mg(0.4mmol)
及びテトラヒドロフラン40mlを入れ,これにマロンニト
リル740mg(11mmol)のテトラヒドロフラン溶液(10m
l)を徐々に添加した。ついでp−イソブチルフェニル
ヨーダイト2601mg(10mmol)及びパラジウムジアセテー
ト45mg(0.2mmol)を加え,5時間還流下に反応させた。
室温まで冷却した後,反応混合物を希塩酸で処理し,エ
ーテルで抽出した。エーテル溶液を濃縮した。この濃縮
物にエトキシナトリウム748mg(0.11mmol)のエタノー
ル溶液20mlをゆっくり加え,ついでメチルヨーダイド17
03mg(0.12mmol)を添加した。混合物を3時間還流下に
反応させた後,アルコールを留去した。この残留物に水
25ml,濃硫酸25mlを加え,120〜130℃で12時間加水分解と
同時に脱炭酸を行なった。室温まで冷却し,エーテルで
生成物を抽出した。精製するため,エーテルを留去し,
生成物をシリカゲルカラムクロマトで分離した。塩化メ
チレン溶媒で溶出して,融点76℃の2−(4−イソブチ
ルフェニル)プロピオン酸(慣用名:イブプロフェン)
1450mg(収率70%)を得た。Example 1 Synthesis of ibuprofen (method A) In a three-necked flask equipped with a reflux condenser, a stirrer, a dropping funnel and a thermometer, 2469 mg of potassium t-butoxide in a nitrogen stream.
(22mmol), triphenylphosphine 105mg (0.4mmol)
And tetrahydrofuran (40 ml) were added, and a solution of malonnitrile (740 mg, 11 mmol) in tetrahydrofuran (10 m
l) was added slowly. Then, 2601 mg (10 mmol) of p-isobutylphenyliodite and 45 mg (0.2 mmol) of palladium diacetate were added, and the mixture was reacted under reflux for 5 hours.
After cooling to room temperature, the reaction mixture was treated with dilute hydrochloric acid and extracted with ether. The ether solution was concentrated. To this concentrate was slowly added 20 ml of an ethanol solution of 748 mg (0.11 mmol) of sodium ethoxy, and then methyl iodide 17 was added.
03 mg (0.12 mmol) was added. After reacting the mixture under reflux for 3 hours, the alcohol was distilled off. Water on this residue
25 ml of concentrated sulfuric acid and 25 ml of concentrated sulfuric acid were added, and decarboxylation was carried out simultaneously with hydrolysis at 120 to 130 ° C for 12 hours. Cool to room temperature and extract the product with ether. For purification, the ether was distilled off,
The products were separated by silica gel column chromatography. 2- (4-isobutylphenyl) propionic acid (common name: ibuprofen) having a melting point of 76 ° C, eluted with a methylene chloride solvent
1450 mg (yield 70%) was obtained.
実施例2 フルルビプロフェンの合成(B法) 実施例1と同様の反応容器に,窒素気流中,t−ブトキシ
カリウム2470mg(22mmol)及びエチレングリコールジメ
チルエーテル40mlを入れ,これにシアノ酢酸エチル1450
mg(13mmol)のエチレングリコールジメチルエーテル溶
液(10ml)を徐徐に加えた。次に2−フロロ−4−ヨー
ドビフェニル2981mg(10mmol)及びジクロロビス(トリ
フェニルホスフィン)パラジウム触媒300mg(0.43mmo
l)を加え,攪拌しながら,70℃で8時間反応させた。反
応混合物を希塩酸処理,エーテル抽出後,濃縮した。こ
の濃縮物にエトキシナトリウム748mg(0.11mmol)のエ
タノール溶液20mlをゆっくり加え,ついでメチルヨーダ
イド1703mg(0.12mmol)を添加した。混合物を3時間還
流下に反応させた後,アルコールを留去した。この残留
物を,実施例1と同様にして,硫酸水溶液で加水分解,
脱炭酸,精製分離を行ない,融点114℃の2−(2−フ
ロロ−4−ビフェニル)プロピオン酸(慣用名:フルル
ビプロフェン)1590mg(収率65%)を得た。Example 2 Synthesis of flurbiprofen (method B) In a reaction vessel similar to that in Example 1, 2470 mg (22 mmol) of potassium t-butoxide and 40 ml of ethylene glycol dimethyl ether were placed in a nitrogen stream, and ethyl cyanoacetate 1450 was added thereto.
A solution of mg (13 mmol) of ethylene glycol dimethyl ether (10 ml) was gradually added. Next, 2-fluoro-4-iodobiphenyl 2981 mg (10 mmol) and dichlorobis (triphenylphosphine) palladium catalyst 300 mg (0.43 mmo
l) was added and reacted at 70 ° C. for 8 hours while stirring. The reaction mixture was treated with diluted hydrochloric acid, extracted with ether and then concentrated. To this concentrate, 20 ml of an ethanol solution of 748 mg (0.11 mmol) of sodium ethoxy was added slowly, and then 1703 mg (0.12 mmol) of methyl iodide was added. After reacting the mixture under reflux for 3 hours, the alcohol was distilled off. This residue was hydrolyzed with an aqueous sulfuric acid solution in the same manner as in Example 1,
Decarboxylation and purification separation were carried out to obtain 1590 mg (yield 65%) of 2- (2-fluoro-4-biphenyl) propionic acid (common name: flurbiprofen) having a melting point of 114 ° C.
実施例3 ケトプロフェンの合成(C法) 脱水器,温度計及び攪拌機を備えた三ツ口フラスコに3
−ヨードベンゾフェノン3081mg(10mmol),エチレング
リコール1860mg(30mmol)及びp−トルエンスルホン酸
100mgを加え,ベンゼン20mlに溶解し,15時間還流下に脱
水を行なった。(脱水量0.18ml/理論脱水量0.18ml)。
得られた3−ヨードベンゾフェノンエチレンケタールの
ベンゼン溶液から溶媒を留去した。Example 3 Synthesis of ketoprofen (method C) 3 in a three-necked flask equipped with a dehydrator, a thermometer and a stirrer
-Iodobenzophenone 3081 mg (10 mmol), ethylene glycol 1860 mg (30 mmol) and p-toluenesulfonic acid
100 mg was added, dissolved in 20 ml of benzene, and dehydrated under reflux for 15 hours. (Dehydration amount 0.18 ml / theoretical dehydration amount 0.18 ml).
The solvent was distilled off from the obtained benzene solution of 3-iodobenzophenone ethylene ketal.
実施例1と同様の反応容器に,窒素気流中,水素化ナト
リウム530mg(22mmol)及びテトラヒドロフラン40mlを
入れ,これにマロンニトリル740mg(11mmol)のテトラ
ヒドロフラン溶液を徐々に滴下した。水素の発生がおさ
まった後,前記で得られた3−ヨードベンゾフェノンエ
チレンケタール(10mmol)のテトラヒドロフラン溶液
(20ml)及びジクロロビス(トリフェニルホスフィン)
パラジウム触媒100mg(0.14mmol)を加え,還流,攪拌
しながら,5時間反応させた。反応混合物を室温まで冷却
した後,希塩酸で処理して,ケタール保護基をはずして
カルボニル基とし,次にエーテル抽出,濃縮を行なっ
た。残留物にエトキシナトリウム748mg(0.11mmol)の
エタノール溶液20mlをゆっくり加え,ついでヨードメチ
ル1703mg(0.12mmol)を添加した。この混合物を3時間
還流した後,アルコールを留去した。この残留物を,実
施例1と同様にして,硫酸水溶液で加水分解,脱炭酸,
精製分離を行ない,融点95℃の3−ベンゾイルハイドラ
トロピック酸(慣用名:ケトプロフェン)1526mg(収率
60%)を得た。In a reaction vessel similar to that of Example 1, 530 mg (22 mmol) of sodium hydride and 40 ml of tetrahydrofuran were placed in a nitrogen stream, and a tetrahydrofuran solution of 740 mg (11 mmol) of malonnitrile was gradually added dropwise thereto. After the generation of hydrogen subsided, a solution of 3-iodobenzophenone ethylene ketal (10 mmol) obtained above in tetrahydrofuran (20 ml) and dichlorobis (triphenylphosphine)
100 mg (0.14 mmol) of palladium catalyst was added, and the mixture was reacted for 5 hours while refluxing and stirring. After the reaction mixture was cooled to room temperature, it was treated with dilute hydrochloric acid to remove the ketal protecting group to give a carbonyl group, and then extracted with ether and concentrated. 20 ml of an ethanol solution of 748 mg (0.11 mmol) of sodium ethoxy was slowly added to the residue, and then 1703 mg (0.12 mmol) of iodomethyl was added. After refluxing this mixture for 3 hours, the alcohol was distilled off. This residue was hydrolyzed with an aqueous sulfuric acid solution, decarboxylated, and treated in the same manner as in Example 1.
Purified and separated, 1526 mg (yield: 3-benzoylhydratropic acid (common name: ketoprofen) with a melting point of 95 ° C.
60%).
実施例4 アルクロフェナックの合成(D法) 実施例1の反応容器に,窒素気流中,水素化ナトリウム
530mg(22mmol)及びテトラヒドロフラン40mlを入れ,
これにマロンニトリル740mg(11mmol)のテトラヒドロ
フラン溶液(10ml)を徐々に添加した。水素の発生がお
さまった後,ベンジル(2−クロロ−4−ヨード)フェ
ニルエーテル3446mg(10mmol)及びジクロロビス(トリ
フェニルホスフィン)パラジウム100mg(0.14mmol)を
加え,攪拌しながら,テトラヒドロフランの還流下に,5
時間反応させた。室温まで冷却した後,反応混合物を希
塩酸で処理し,エーテルで抽出した。Example 4 Synthesis of Alcrofenac (Method D) Sodium hydride was placed in the reaction vessel of Example 1 in a nitrogen stream.
Add 530 mg (22 mmol) and 40 ml of tetrahydrofuran,
A tetrahydrofuran solution (10 ml) of 740 mg (11 mmol) of malon nitrile was gradually added thereto. After the generation of hydrogen subsided, 3446 mg (10 mmol) of benzyl (2-chloro-4-iodo) phenyl ether and 100 mg (0.14 mmol) of dichlorobis (triphenylphosphine) palladium were added, and the mixture was refluxed with tetrahydrofuran while stirring. Five
Reacted for hours. After cooling to room temperature, the reaction mixture was treated with dilute hydrochloric acid and extracted with ether.
エーテル溶液を濃縮した後,無水n−ブタノール25mlを
添加し,50℃に保ちながら,ナトリウム230mg(10mmol)
をすばやく入れて反応を行なった。ナトリウムが完全に
消失してから,冷却し希塩酸で中和した。有機層を乾燥
した後,n−ブタノールを完全に留去した。反応混合物を
アセトン20mlに溶解し,炭酸カリウム1380mg,ヨウ化カ
リウム80mg及びアリルクロライド840mg(11mmol)を一
度に添加し,8時間還流下に反応させた。室温まで冷却し
てから過を行ない,液のアセトン溶液からアセトン
を留去した。反応生成物に水25ml及び濃硫酸25mlを加
え,120〜130℃で12時間加水分解と同時に脱炭酸を行な
った。その後は実施例1と同様にして,エーテル抽出,
精製分離を行ない,融点92〜93℃の4−アリルオキシ−
3−クロロフェニル酢酸(慣用名:アルクロフェナッ
ク)1670mg(収率73%)を得た。After concentrating the ether solution, 25 ml of anhydrous n-butanol was added, and while maintaining the temperature at 50 ° C, sodium 230 mg (10 mmol)
Was quickly added to carry out the reaction. After the sodium had completely disappeared, it was cooled and neutralized with dilute hydrochloric acid. After drying the organic layer, n-butanol was completely distilled off. The reaction mixture was dissolved in 20 ml of acetone, 1380 mg of potassium carbonate, 80 mg of potassium iodide and 840 mg (11 mmol) of allyl chloride were added at once, and the mixture was reacted under reflux for 8 hours. After cooling to room temperature, an excess was performed, and acetone was distilled off from the liquid acetone solution. 25 ml of water and 25 ml of concentrated sulfuric acid were added to the reaction product, and decarboxylation was carried out simultaneously with hydrolysis at 120-130 ℃ for 12 hours. Thereafter, in the same manner as in Example 1, extraction with ether,
Purified and separated, 4-allyloxy-, melting point 92-93 ℃
1670 mg (yield 73%) of 3-chlorophenylacetic acid (conventional name: alclofenac) was obtained.
実施例5〜10 第1−1表及び第1−2表記載の芳香族ハライド10mmo
l,ニトリル化合物及び触媒を用い,その後は前記A〜D
法に従い本発明の芳香族置換アルキルカルボン酸を得
た。Examples 5-10 10 mmo of aromatic halide described in Table 1-1 and Table 1-2
l, a nitrile compound and a catalyst, and then the above
The aromatic substituted alkylcarboxylic acid of the present invention was obtained according to the method.
A〜D法とは次のことを意味する。The methods A to D mean the following.
A法:マロンニトリルとの反応後,メチル化し,加水分
解及び脱炭酸を行なった。Method A: After reaction with malonnitrile, methylation, hydrolysis and decarboxylation were carried out.
B法:シアノ酢酸エステルとの反応後,メチル化し,加
水分解及び脱炭酸を行なった。Method B: After reaction with cyanoacetic acid ester, methylation was carried out, followed by hydrolysis and decarboxylation.
C法:カルボニル基を予め保護し,マロンニトリルとの
反応後,メチル化し,加水分解及び脱炭酸を行なった。Method C: The carbonyl group was previously protected, and after reaction with malonnitrile, methylation was carried out, followed by hydrolysis and decarboxylation.
D法:マロンニトリルとの反応後,アリル基を導入し,
加水分解及び脱炭酸を行なった。Method D: After reaction with malonnitrile, introduction of an allyl group,
Hydrolysis and decarboxylation were performed.
以上の結果を第1−1表及び第1−2表にまとめた。The above results are summarized in Tables 1-1 and 1-2.
(注)第1−1表〜第1−2表中の記号は次のことを表
わす。 (Note) The symbols in Tables 1-1 to 1-2 represent the following.
Ph:フェニル,Et:エチル基,Me:メチル基,COD:シクロオク
タジエン,CHD:シクロヘキサジエン。Ph: phenyl, Et: ethyl group, Me: methyl group, COD: cyclooctadiene, CHD: cyclohexadiene.
実施例11〜17 実施例1と同じ反応容器に,下記第2表の塩基性縮合剤
及び溶媒を入れ,マロンニトリル740mg(11mmol)の溶
液を徐々に加えた。次に2−フロロ−4−ヨードビフェ
ニル2981mg(10mmol)と下記第2表の触媒を添加し,反
応させた。その後は実施例1と同様にして,メチル化,
加水分解,脱炭酸及び分離精製を行ない,融点113〜114
℃の2−(2−(フロロ−4−ビフェニル)プロピオン
酸(反応生成物)を得た。Examples 11 to 17 The same reaction vessel as in Example 1 was charged with the basic condensing agent and solvent shown in Table 2 below, and a solution of 740 mg (11 mmol) malonnitrile was gradually added. Next, 2981 mg (10 mmol) of 2-fluoro-4-iodobiphenyl and the catalyst shown in Table 2 below were added and reacted. Thereafter, in the same manner as in Example 1, methylation,
Hydrolysis, decarboxylation, separation and purification, melting point 113-114
Thus, 2- (2- (fluoro-4-biphenyl) propionic acid (reaction product) at ℃ was obtained.
結果を第2表に示した。The results are shown in Table 2.
(注)第2表中の記号は次のことを表わす。 (Note) The symbols in Table 2 indicate the following.
Me:メチル基,Et:エチル基,Bu:ブチル基,Ph:フェニル基,
acac:アセチルアセトナート基,COD:シクロオクタジエ
ン,NBD:ノボルナジエン。Me: methyl group, Et: ethyl group, Bu: butyl group, Ph: phenyl group,
acac: acetylacetonate group, COD: cyclooctadiene, NBD: nobornadiene.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C07C 59/84 8930−4H C07D 207/20 8217−4C 209/46 9284−4C 333/22 // B01J 31/22 X 8017−4G 31/24 X 8017−4G C07B 61/00 300 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI technical display location C07C 59/84 8930-4H C07D 207/20 8217-4C 209/46 9284-4C 333/22 // B01J 31/22 X 8017-4G 31/24 X 8017-4G C07B 61/00 300
Claims (1)
環式基を,Xは臭素原子又はヨウ素原子をそれぞれ示す)
で表わされる芳香族ハライドに 一般式〔II〕 〔式中Rは水素原子又はメチル基を,Yはシアン基又は基
−COOR1(R1はアルキル基,アラルキル基又はアリール
基)を示す〕で表わされるニトリル化合物を,触媒とし
て, 一般式〔IIIa〕〜〔IIIc〕 L2Pd(II)▲X* 2▼ 〔IIIa〕 L4Pd(O) 〔IIIb〕 QaPd(II)▲X* b▼+L 〔IIIc〕 〔式中Lは (R2,R3又はR4はアルキル基,アルケニル基,アラルキ
ル基,アリール基,シクロアルキル基,アルコキシ基又
はアリールオキシ基から独立して選ばれた基を示し,
R2,R3又はR4が他の分子のR2,R3又はR4と互に結合し,
少くとも1個のアルキレン基又はアルキレンエーテル基
を形成してL2を構成していてもよい)で表わされる配位
子を,Qはニトリル類,イソニトリル類,π−アリル,1,5
−ジエン類,1,3−ジエン類,ベンゾキノン又はオレフィ
ン類を示し,但しこれらの化合物はPd(II)錯体を形成
するものとしX*はハロゲン原子,基−OOCR5(R5は低級
アルキル基)又は を,a及びbは1又は2の整数をそれぞれ示す〕で表わさ
れる二価又はO価のパラジウム化合物から選ばれる少く
とも1種を用いて反応させ,相当する芳香族置換マロン
ニトリル又はシアン酢酸エステルとし,次いでこの化合
物を (a) 酸又はアルカリの存在下で加水分解し,加熱に
より脱炭酸を行なうか, (b) 塩基性縮合剤の存在下でメチルハライドにより
メチル化し,加水分解後加熱により脱炭酸を行なうこと
を特徴とする 一般式〔IV〕 (式中Ar及びRは前記と同じ意義を有する)で表わされ
る芳香族置換アルキルカルボン酸化合物の製造法。1. A compound represented by the general formula [I] Ar-X [I] (wherein Ar represents a substituted aryl group or a substituted or unsubstituted heterocyclic group, and X represents the presence of a catalyst, a basic condensing agent and a solvent). Indicates a bromine atom or an iodine atom, respectively)
The aromatic halide represented by the general formula [II] [Wherein R represents a hydrogen atom or a methyl group, Y represents a cyan group or a group-COOR 1 (R 1 represents an alkyl group, an aralkyl group or an aryl group)], using a nitrile compound represented by the general formula [ IIIa] to [IIIc] L 2 Pd (II) ▲ X * 2 ▼ [IIIa] L 4 Pd (O) [IIIb] QaPd (II) ▲ X * b ▼ + L [IIIc] [where L is (R 2 , R 3 or R 4 represents a group independently selected from an alkyl group, an alkenyl group, an aralkyl group, an aryl group, a cycloalkyl group, an alkoxy group or an aryloxy group,
R 2, R 3 or R 4 is mutually bonded with R 2, R 3 or R 4 other molecules,
At least a ligand represented by the structure may be in) one of L 2 to form an alkylene group or an alkylene ether group, Q is a nitrile, isonitriles, .pi.-allyl, 1,5
-Diene, 1,3-diene, benzoquinone or olefin, provided that these compounds form a Pd (II) complex, X * is a halogen atom, and -OOCR 5 (R 5 is a lower alkyl group) ) Or A and b each represent an integer of 1 or 2] and are reacted with at least one divalent or O-valent palladium compound, and the corresponding aromatic-substituted malonnitrile or cyanoacetic acid ester is reacted. Then, this compound is (a) hydrolyzed in the presence of an acid or alkali and decarboxylated by heating, or (b) methylated with methyl halide in the presence of a basic condensing agent, and then heated after hydrolysis. General formula [IV] characterized by decarboxylation A method for producing an aromatic-substituted alkylcarboxylic acid compound represented by the formula (wherein Ar and R have the same meanings as described above).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60159317A JPH0684331B2 (en) | 1985-07-18 | 1985-07-18 | Process for producing aromatic substituted alkylcarboxylic acid compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60159317A JPH0684331B2 (en) | 1985-07-18 | 1985-07-18 | Process for producing aromatic substituted alkylcarboxylic acid compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6219551A JPS6219551A (en) | 1987-01-28 |
| JPH0684331B2 true JPH0684331B2 (en) | 1994-10-26 |
Family
ID=15691149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60159317A Expired - Fee Related JPH0684331B2 (en) | 1985-07-18 | 1985-07-18 | Process for producing aromatic substituted alkylcarboxylic acid compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0684331B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0730822Y2 (en) * | 1989-06-02 | 1995-07-19 | 東リ株式会社 | Multicolor effect flooring |
| JP6765144B1 (en) | 2019-07-18 | 2020-10-07 | 株式会社 エコファクトリー | Ventilation air conditioning structure |
-
1985
- 1985-07-18 JP JP60159317A patent/JPH0684331B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6219551A (en) | 1987-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Synthesis of novel N, P chiral ligands for palladium-catalyzed asymmetric allylations: the effect of binaphthyl backbone on the enantioselectivity | |
| CN108276287B (en) | Synthesis method of 4-oxo acrylate derivative catalyzed by visible light | |
| EP0711749B1 (en) | Process for producing geranylgeraniol | |
| Cho et al. | Facile palladium-catalyzed carbonylation of triarylstibines in the presence of ammonium cerium (IV) nitrate | |
| EP0074008B1 (en) | Process for producing alpha-arylalkanoic acid esters | |
| EP0633238A2 (en) | Asymmetric catalytic hydrogenation of alpha-arylpropenoic acids | |
| JPH0684331B2 (en) | Process for producing aromatic substituted alkylcarboxylic acid compound | |
| CN113336667B (en) | Method suitable for industrial production of intermediate of roxasistat | |
| JPH0625094A (en) | Production of cinnamic acid derivative | |
| JPS5995238A (en) | Method for producing phenylacetic acid derivatives | |
| US5223640A (en) | Preparation of optically active α-aryl propionic acids | |
| CN108250008B (en) | Chiral resolution method of 3,3,3',3' -tetramethyl-1, 1 '-spiroindane-6, 6' -diol derivative | |
| JP2002030005A (en) | Method for manufacturing aryl ester of carboxylic acid | |
| CN115703806B (en) | Phosphine ligand of pyrazole-amide framework, and preparation method and application thereof | |
| US3920746A (en) | Preparation of tertiary-butyl aryl ethers | |
| CN116655532B (en) | A rosuvastatin intermediate and its preparation method | |
| US4927945A (en) | Process for preparing diphenyl ethers | |
| US4575561A (en) | Carboxyalkylation of aryl-substituted alkyl halides to the corresponding esters | |
| EP0110671B1 (en) | Preparation of optically active alpha-arylalkanoic acids and precursors thereof | |
| US5587510A (en) | (S)-2-aralkyl-3-chloropropionic acid and process for the preparation thereof | |
| JP2903233B2 (en) | Method for producing high-purity dimethyl diphenyldicarboxylate | |
| RU2053994C1 (en) | Method for production of aromatic dicarboxylic acids | |
| Saegusa et al. | Synthetic reactions by complex catalysts. XXIX. Esterification of carboxylic acid with alkyl halide by means of copper (I)-isonitrile complex | |
| JPH01139566A (en) | Production of pyridine-2,3-dicarboxylic derivative | |
| CN119552102A (en) | A method for synthesizing dialkyl selenide compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |